Neurona Therapeutics
neuronatherapeutics.com
Cell & Gene Therapy
Biotechnology
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Neural Cell Therapy Reduce Seizures in MTLE CGTlive
Updated data were presented at the AES annual meeting in Nashville.
Read more
Report
Inhibitory Interneuron Cell Therapy Reduces Seizures in First 2 Patients With MTLE CGTlive
Data from a phase 1/2 clinical trial of NRTX-1001 were presented at the ISSCR 2023 Annual Meeting.
Read more
Report
Exploring Cell Therapy for the Treatment of Drug-Resistant Epilepsy CGTlive
Cory Nicholas, PhD, cofounder and chief executive officer, Neurona Therapeutics, discussed the company's lead program in mesial temporal lobe epilepsy.
Read more
Report
Cell therapy biotech Neurona nabs 102M to push epilepsy candidate into phase 3
August 25, 2025 Regenerative medicine offers new hope for lasting seizure relief for drug-resistant epilepsy
Read more
Report
Exclusive: Neurona bags 102M to treat epilepsy with cell therapy
August 25, 2025 Regenerative medicine offers new hope for lasting seizure relief for drug-resistant epilepsy
Read more
Report
First-of-its-kind stem-cell transplant treatment targets drug-resistant focal epilepsy - UChicago Medicine
After years of debilitating seizures, Jonathan Nemeth is seizure-free thanks to a groundbreaking stem cell therapy from UChicago Medicine
Read more
Report
Brain, Heal Thyself
For some, having their brain injected with new brain cells may seem outrageous, but for Annette Adkins the procedure was a welcome development.
Read more
Report
UChicago Medicine Doctors Provide Pioneering Stem Cell Surgery to Patient with Drug-Resistant Epilepsy Newswise
UChicago Medicine neurosurgeons have performed the world's first bilateral stem cell transplant to treat drug-resistant mesial temporal lobe epilepsy - a groundbreaking procedure offering new hope for seizure control.
Read more
Report
Stem Cells in Epilepsy: Innovations and Challenges in Neurosurgical Treatment
June 19, 2025 UChicago Medicine doctors provide pioneering stem cell surgery to patient with drug-resistant epilepsy
Read more
Report
Neurona raises 120M to take epilepsy cell therapy to late-stage development
February 17, 2025 Stem Cells in Epilepsy: Innovations and Challenges in Neurosurgical Treatment
Read more
Report
Show more news
People
Tim Kutzkey
Director
Cory Nicholas
Executive Officer, Director
James Stutz
Executive Officer
Arnold Kriegstein
Director
Stephen Hauser
Director
David Goeddel
Director
Leo Guthart
Director
Robert Tijan
Director
Robert Tjian
Director
Erica Whittaker
Director
Brad Margus
Director
Ray Kelleher
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
South San Francisco
United States
HQ
Contact Us
1000-5000 est. staff
490 Forbes Blvd, Suite 600, South San Francisco, CA 94080
Financials
Total raised
$347.5M
Latest round
Venture - Series Unknown
Funding rounds
6
Funding rounds